To comprehensively assess the association between positive drug target genes and susceptibility to rotator cuff syndrome, our study utilized genetic variations linked to the expression of HMGCR and PCSK9 in whole blood and various tissues as instrumental variables. This evidence concerns the gene PCSK9 and rotator cuff syndrome.